financetom
Business
financetom
/
Business
/
Hims & Hers Health Says Data Show Personalized Weight Loss Plans Drive 'Meaningful' Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hims & Hers Health Says Data Show Personalized Weight Loss Plans Drive 'Meaningful' Results
Jul 29, 2025 7:14 AM

09:41 AM EDT, 07/29/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Tuesday that new data showed its personalized GLP-1 weight loss programs drove "meaningful, sustainable" results for its customers.

In an analysis of US treatment plans, customers taking a compounded GLP-1 reported losing an average of 10.3% of initial body weight within six months, while only 10.3% reported side effects, the company said.

Data also showed that 75% of customers remained on treatment plans in the same timeframe, the company said.

Price: 57.75, Change: -0.93, Percent Change: -1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
German Regulator Clears Rivian's Joint Venture With Volkswagen; Acquisition Stake
German Regulator Clears Rivian's Joint Venture With Volkswagen; Acquisition Stake
Jul 29, 2024
08:15 AM EDT, 07/29/2024 (MT Newswires) -- German competition regulator Bundeskartellamt has approved Rivian Automotive's ( RIVN ) joint venture with German automaker Volkswagen, as well as Volkswagen's acquisition of a minority stake in the electric vehicle maker. When it comes to cooperation projects set up to develop new products and technologies in key cutting-edge sectors, particularly those involving large...
AstraZeneca says Calquence With Venetoclax Showed Significant Improvement in Survival in Leukemia Patients
AstraZeneca says Calquence With Venetoclax Showed Significant Improvement in Survival in Leukemia Patients
Jul 29, 2024
08:19 AM EDT, 07/29/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Monday that Calquence with venetoclax showed a statistically significant and clinically meaningful improvement in progression-free survival compared to chemoimmunotherapy in previously untreated adult patients with chronic lymphocytic leukemia in a phase 3 trial interim analysis. The safety and tolerability were consistent with the known safety profile of each...
Toyota chairman warns he may lose board spot if investor support continues to fall
Toyota chairman warns he may lose board spot if investor support continues to fall
Jul 29, 2024
TOKYO (Reuters) - Toyota Motor ( TM ) Chairman Akio Toyoda said he may not be reelected as a director if shareholder support for him continues to fall at the pace it did this year, according to an interview published on Monday. Shareholder backing for Toyoda slid to 72% at the company's annual general meeting last month, following proxy advisers'...
G-III Apparel Group Increases Stake in All We Wear Group
G-III Apparel Group Increases Stake in All We Wear Group
Jul 29, 2024
08:18 AM EDT, 07/29/2024 (MT Newswires) -- G-III Apparel Group ( GIII ) said Monday it has increased its stake in All We Wear Group to about 19% from 12%. All We Wear Group owns the Pepe Jeans London, Hackett and Faconnable brands. Price: 26.72, Change: +0.07, Percent Change: +0.26 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved